Fascinating work by AION—bioelectric control could redefine regenerative medicine. But the hardware demands precision, and I wonder how export controls on advanced AI chips (like those in a piece I read) might impact such research. Scaling this tech needs unfettered access to compute.
https://theboard.world/articles/us-control-global-ai-chip-sales
